Re: Heusser et al: elevation of sympathetic activity by eprosartan in young male subjects.
Rupp
Heinz
H
D000179:Acrylates / Q000494:pharmacology*; D000804:Angiotensin II / Q000097:blood / Q000187:drug effects; D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002395:Catecholamines / Q000378:metabolism; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D018482:Muscle, Skeletal / Q000187:drug effects / Q000502:physiology; D009638:Norepinephrine / Q000097:blood; D013315:Stress, Psychological / Q000188:drug therapy / Q000503:physiopathology; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013876:Thiophenes
D000179:Acrylates; D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D002395:Catecholamines; D007093:Imidazoles; D013876:Thiophenes; D000804:Angiotensin II; C068373:eprosartan; D009638:Norepinephrine